Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
苗药正醒散 (Miao Medicine Zhengxing Powder) is a traditional Miao herbal formulation developed by the Guizhou Miao Ridge Miao Medicine Research Institute (also known as Guizhou Miaoyao Pharmaceutical) for the treatment of leukemia. As a traditional ethnic medicine from the Guizhou region of China, it is associated with patent ZL200910102617.3. The product is typically prepared as a powder and is used within the framework of traditional Miao medical practices. Like many traditional herbal medicines, its specific molecular targets and pharmacological mechanisms of action have not been characterized through standard Western clinical trial phases or molecular biology studies, but it is marketed specifically for its therapeutic potential in leukemia patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 苗药正醒散.